Drug-drug Interaction Study Between UIC201601 and UIC201602

NCT05190133 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Korea United Pharm. Inc.